Home > Boards > US Listed > Biotechs > Aurinia Pharmaceuticals Inc (AUPH)

ITRM = Well, if it doesn't work at

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
lidopete Member Profile
 
Followed By 0
Posts 552
Boards Moderated 0
Alias Born 07/16/06
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/22/2021 4:31:38 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 9/17/2021 4:04:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2021 5:02:32 PM
Aurinia Pharmaceuticals to Present at Upcoming September Investor Conferences Business Wire - 9/15/2021 1:11:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/14/2021 6:17:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/14/2021 5:12:58 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/14/2021 5:11:39 PM
Aurinia Pharmaceuticals to Participate in H.C. Wainwright 23rd Annual Global Investment Conference Business Wire - 9/10/2021 1:30:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/8/2021 4:05:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/8/2021 4:04:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/27/2021 4:16:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/26/2021 4:16:49 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/17/2021 4:07:54 PM
Aurinia Acquires Novel Pipeline Assets Targeting Autoimmune and Kidney-related Diseases Business Wire - 8/17/2021 6:05:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/10/2021 4:09:58 PM
Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotech Conference Business Wire - 8/9/2021 7:55:00 AM
SCWorx, Aurinia Pharmaceuticals leads healthcare gainers; Dicerna Pharmaceuticals, iCAD among major losers Seeking Alpha - 8/6/2021 11:02:32 AM
Aurinia Pharma extends gains following robust Q2 top-line growth Seeking Alpha - 8/6/2021 6:08:45 AM
Aurinia Pharma EPS misses by $0.01, beats on revenue Seeking Alpha - 8/5/2021 4:16:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2021 4:14:46 PM
Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights Business Wire - 8/5/2021 4:05:00 PM
Eyes will be on Aurinia's lupus drug Lupkynis during Q2 2021 earnings today Seeking Alpha - 8/5/2021 11:46:57 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/29/2021 4:11:23 PM
Aurinia Pharmaceuticals to Release Second Quarter 2021 Financial Results on August 5, 2021 Business Wire - 7/26/2021 6:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/19/2021 6:02:19 AM
lidopete   Wednesday, 12/16/20 11:25:04 PM
Re: nferna post# 11485
Post # of 13638 
ITRM = Well, if it doesn't work at least they have a patent

Interum Therapeutics announces filing of U.S. patent application

Iterum Therapeutics announced the filing of a U.S. national phase patent application directed to the composition of the bilayer tablet of sulopenem etzadroxil and probenecid and its related uses with the U.S. Patent and Trademark Office. The sulopenem bilayer tablet contains sulopenem etzadroxil, a prodrug of sulopenem that enables oral bioavailability, and probenecid, a renal tubular transport blocking agent, which together enhance the exposure of sulopenem to the bacterial pathogen responsible for the infection. These claims encompass the oral formulation used in the Phase 3 registration studies to support the safety and efficacy of sulopenem etzadroxil and probenecid. An extension of the life of the patent estate would enable pursuit of claims related to our previously granted QIDP indications such as pneumonia.




Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences